Literature DB >> 30017816

Silent cerebral events/lesions after second-generation cryoballoon ablation: How can we reduce the risk of silent strokes?

Shinsuke Miyazaki1, Takatsugu Kajiyama2, Kazuya Yamao2, Masahiro Hada2, Masao Yamaguchi2, Hiroaki Nakamura2, Hitoshi Hachiya2, Hiroshi Tada3, Kenzo Hirao4, Yoshito Iesaka2.   

Abstract

BACKGROUND: Atrial fibrillation (AF) ablation is associated with a substantial risk of silent cerebral events/lesions (SCEs/SCLs) detected on magnetic resonance imaging (MRI).
OBJECTIVE: The purpose of this study was to investigate the factors associated with the incidence of SCEs/SCLs during second-generation cryoballoon ablation.
METHODS: Two hundred fifty-six AF patients underwent brain MRI 1 day after pulmonary vein (PV) isolation using second-generation cryoballoons with a single 28-mm balloon and short freeze strategy.
RESULTS: Overall, 991 of 1016 PVs (97.5%) were successfully isolated by 4.9 ± 1.3 cryoballoon applications per patient, and 25 PVs required touch-up radiofrequency ablation. The total procedure time was 72.7 ± 26.1 minutes. SCEs and SCLs were detected in 68 (26.5%) and 27 (10.5%) patients, respectively. None of the patients reported any neurologic symptoms. Reinsertion of once withdrawn cryoballoons and subsequent applications significantly increased the incidence of SCEs (odds ratio [OR] 2.057; 95% confidential interval [CI] 1.051-4.028; P = .035), and additional left atrial mapping with a multielectrode catheter significantly increased the incidence of SCLs (OR 3.317; 95% CI 1.365-8.056; P = .008). Transient coronary air embolisms were significantly associated with the incidence of SCLs (OR 3.447; 95% CI 1.015-11.702; P = 0.047). On the contrary, an uninterrupted anticoagulation regimen, use of radiofrequency deliveries for transseptal access, cryoballoon air removal with extracorporeal balloon inflations, strength of the MRI magnet, internal electrical cardioversion, and touch-up ablation were not associated with the incidence of SCEs/SCLs.
CONCLUSION: A significant number of SCE/SCL occurrences was observed after second-generation cryoballoon ablation procedures. These results suggest that air embolisms are the main mechanism of SCEs/SCLs, and the injected air volume might determine the lesion type.
Copyright © 2018 Heart Rhythm Society. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Atrial fibrillation; Catheter ablation; Cryoballoon; Pulmonary vein isolation; Silent stroke

Year:  2018        PMID: 30017816     DOI: 10.1016/j.hrthm.2018.07.011

Source DB:  PubMed          Journal:  Heart Rhythm        ISSN: 1547-5271            Impact factor:   6.343


  8 in total

1.  Differences in prothrombotic response between the uninterrupted and interrupted apixaban therapies in patients undergoing cryoballoon ablation for paroxysmal atrial fibrillation: a randomized controlled study.

Authors:  Monami Ando; Yasuya Inden; Yukihiko Yoshida; Akinori Sairaku; Satoshi Yanagisawa; Hirohiko Suzuki; Ryo Watanabe; Masaki Takenaka; Mayuho Maeda; Toyoaki Murohara
Journal:  Heart Vessels       Date:  2019-03-06       Impact factor: 2.037

2.  Thromboembolism and bleeding risk in atrial fibrillation ablation with uninterrupted anticoagulation between new oral anticoagulants and vitamin K antagonists: insights from an updated meta-analysis.

Authors:  Xiao-Hua Liu; Xiao-Fei Gao; Chao-Feng Chen; Bin Chen; Yi-Zhou Xu
Journal:  J Thromb Thrombolysis       Date:  2020-07       Impact factor: 2.300

Review 3.  Innovations in atrial fibrillation ablation.

Authors:  Jitae A Kim; Khurrum Khan; Riyad Kherallah; Shamis Khan; Ishan Kamat; Owais Ulhaq; Qussay Marashly; Mihail G Chelu
Journal:  J Interv Card Electrophysiol       Date:  2022-04-11       Impact factor: 1.900

4.  Safety, effectiveness, and quality of life following pulmonary vein isolation with a multi-electrode radiofrequency balloon catheter in paroxysmal atrial fibrillation: 1-year outcomes from SHINE.

Authors:  Richard Schilling; Gurpreet Singh Dhillon; Claudio Tondo; Stefania Riva; Massimo Grimaldi; Federico Quadrini; Petr Neuzil; Gian-Battista Chierchia; Carlo de Asmundis; Ahmed Abdelaal; Liesbeth Vanderlinden; Tiffany Tan; Wern Yew Ding; Dhiraj Gupta; Vivek Y Reddy
Journal:  Europace       Date:  2021-06-07       Impact factor: 5.214

5.  Thromboembolic Events Following Atrial Fibrillation Cardioversion and Ablation: What's the Culprit?

Authors:  Francesco De Sensi; Gennaro Miracapillo; Luigi Addonisio; Marco Breschi; Alberto Cresti; Pasquale Baratta; Francesco Paneni; Ugo Limbruno
Journal:  Medicina (Kaunas)       Date:  2019-08-20       Impact factor: 2.430

6.  Outcomes of uninterrupted vs interrupted Periprocedural direct oral Anticoagulants in atrial Fibrillation ablation: A meta-analysis.

Authors:  Indranill Basu-Ray; Dibbendhu Khanra; Péter Kupó; Jared Bunch; Sue A Theus; Anindya Mukherjee; Sumit K Shah; András Komócsi; Adedayo Adeboye; John Jefferies
Journal:  J Arrhythm       Date:  2021-01-29

7.  Effect of air removal with extracorporeal balloon inflation on incidence of asymptomatic cerebral embolism during cryoballoon ablation of atrial fibrillation: A prospective randomized study.

Authors:  Masaaki Yokoyama; Michifumi Tokuda; Kenichi Tokutake; Hidenori Sato; Hirotsuna Oseto; Kenichi Yokoyama; Mika Kato; Ryohsuke Narui; Shin-Ichi Tanigawa; Seigo Yamashita; Michihiro Yoshimura; Teiichi Yamane
Journal:  Int J Cardiol Heart Vasc       Date:  2022-04-07

8.  KLF15 Loss-of-Function Mutation Underlying Atrial Fibrillation as well as Ventricular Arrhythmias and Cardiomyopathy.

Authors:  Ning Li; Ying-Jia Xu; Hong-Yu Shi; Chen-Xi Yang; Yu-Han Guo; Ruo-Gu Li; Xing-Biao Qiu; Yi-Qing Yang; Min Zhang
Journal:  Genes (Basel)       Date:  2021-03-12       Impact factor: 4.096

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.